ARCHIVES

Abraxane Combination Improves Survival In Treatment-Naïve Metastatic Disease

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Peter Pisters named CEO of University Health Network in Toronto

August 8, 2014

DCT Board Approves New Screening Program, Natural Product Concpets

March 1, 1985

Impath Buys Clinical Studies Support Services Network.

September 28, 2001

Female Smokers Face Double Risk For Lung Cancer

July 28, 2006

Wilding named director, Univ. of Wisconsin Cancer Center.

January 30, 2004

NTP Board Plans Peer Review Of Bioassay Reports

April 11, 1980